Analyst Ratings for Ligand Pharmaceuticals Inc. (LGND)

Updated: 2017-07-28

Ligand Pharmaceuticals Inc. (NASDAQ:LGND) was awarded an average rating of Buy from investment analysts following the stock. LGND had previously received a consensus rating of Buy a month ago.

4 analysts declared LGND a buy, 0 gave an overweight rating, 1 issued a hold rating, 0 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. During this time, the number of analysts bearish on the stock has increased by 0.

Investment analysts gave a few price targets for LGND. The most optimistic price target was 160, implying a possible profit of 31.95 percent. The most pessimistic price target was 103, implying potential capital losses of -15.06 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.

Analysts have revised their earnings estimates upwards for this quarter, by about 5.46 percent on average, compared to last month. That number becomes -21.71 percent if we expand the time horizon to include the past 3 months instead of just one. Meanwhile, fiscal year estimates have been revised upwards by 0.73 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -5.94 percent.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. Over the past month, 2 analysts increased their quarterly estimates, which can be compared to the 0 analysts that decreased their estimates. Also over the last month, 1 analysts increased their estimates for the FY earnings, while 0 analysts made negative revisions to their fiscal year's estimates.

In the last 52-weeks, LGND has achieved a high of 139.79 and a low of 87.50. The current market price is above the trailing year's low by 38.58 percent, and 13.26 percent below the high. LGND has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The LGND value stock report compares LGND to some of its peers using value stock charts. The market cap of LGND is $2.54 billion. LGND's next earnings release will be on 0000-00-00, which is days away.